Summit Therapeutics (SMMT) Surges 80% on Sarepta (SRPT) Deal

October 4, 2016 8:56 AM EDT Send to a Friend

Summit Therapeutics (NASDAQ: SMMT) is trading up 80% in pre-open trade after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Summit Therapeutics (SMMT) Surges 80% on Sarepta (SRPT) Deal

Member Login

Free News Feed